Average Co-Inventor Count = 5.76
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Newlink Genetics Corporation (18 from 21 patents)
2. Lumos Pharma, Inc. (1 from 9 patents)
3. Lankeanau Institute for Medical Research (1 from 1 patent)
19 patents:
1. 11485705 - Salts and prodrugs of 1-methyl-d-tryptophan
2. 10233190 - IDO inhibitors
3. 10207990 - Salts and prodrugs of 1-methyl-D-tryptophan
4. 10047066 - IDO inhibitors
5. 9981973 - Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolization
6. 9850248 - IDO inhibitors
7. 9732035 - Salts and prodrugs of 1-methyl-D-tryptophan
8. 9617272 - Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolization
9. 9512158 - Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes
10. 9388191 - Fused imidazole derivatives useful as IDO inhibitors
11. 9260434 - Fused imidazole derivatives useful as IDO inhibitors
12. 9174942 - IDO inhibitors
13. 9090643 - Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes
14. 8916169 - Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes
15. 8748469 - IDO inhibitors